The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis

Rosalie A. Scholtes, Daniël H. van Raalte, Ricardo Correa-Rotter, Robert D. Toto, Hiddo J.L. Heerspink, Valerie Cain, C. David Sjöström, Peter Sartipy, Bergur V. Stefánsson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences